Loading clinical trials...
Loading clinical trials...
A Phase I Study Of Medi 522 In Patients With Advanced Tumors
Conditions
Interventions
etaracizumab
Locations
1
United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
Start Date
October 1, 2002
Primary Completion Date
February 1, 2006
Completion Date
February 1, 2006
Last Updated
December 13, 2019
NCT07388563
NCT06337318
NCT06263491
NCT05529069
NCT05139017
NCT07350863
Lead Sponsor
University of Wisconsin, Madison
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions